Metvix PDT for Actinic Keratosis - Clinical Results
PhotoCures multicenter study (phase II) for pre-cancerous actinic keratosis (AK) lesions has taken place at 7 university hospitals in 6 European countries and results from the 3 months follow-up of this study are reported below.In this multicenter study the Metvix cream at two concentrations (80 mg/g and 160 mg/g) is applied on the skin for either 1 or 3 hours before illumination with red light. A total of 112 patients with a total of 384 lesions of AK were treated. Approximately 60% of the patients were treated once, whereas the rest received 2 treatments. 79 90% of the patients